Patients seeking vision correction now have an exciting new option: Visian ICL™, an implantable contact lens. Visian ICL™ is the first foldable lens of its kind to receive FDA approval. Unlike traditional contact lenses that are placed on the surface of the eye, Visian ICL™ is surgically placed inside the eye where it may provide exceptional quality of vision and predictable outcomes. Just when you thought you had seen it all, a new procedure is set to redefine vision correction. Named Visian ICL™, the procedure corrects vision from a completely different perspective. Visian ICL™ is the first lens of its kind to receive FDA approval for use in the United States. After LASIK was introduced many people thought that vision correction had acheived its ultimate evolution. Now there is reason to reconsider, as a new vision correction procedure has received FDA approval for use in the United States. The new procedure is Visian ICL™.
The simple implantation procedure is performed on an outpatient basis by ophthalmologists who are certified in the Visian ICL™ procedure. According to Dr. Alan Faulkner, “It’s the same procedure that I have performed on cataract patients for years, so it’s quite familiar to me.” The ophthalmologist makes a small incision where the cornea meets the white part of the eye and inserts the foldable lens, which unfolds into place. The procedure takes 15 to 30 minutes and is done using topical anesthesia. Typically, patients can see very clearly within a few hours after the procedure. Visian ICL™ is cosmetically pleasing, as well. The lens is placed in the posterior chamber, between the iris and in front of the crystalline lens. The placement makes it invisible to the patient and others. Further, the lens avoids contact with any eye structures, providing safety, stability, comfort and predictable outcomes. Once in place, the lens stays there indefinitely and should require no maintenance. Except for outstanding vision and an annual checkup, the patient may forget the lens is even there. Visian ICL™ is made of an advanced lens material called Collamer® that may provide exceptionally clear vision and practically eliminates reflectance of light that can cause glare, halos and compromised night vision.
A highly biocompatible lens material, Collamer® does not trigger an inflammatory response in the body and minimizes the occurrence of inflammation, induced astigmatism, and other complications.More than 55,000 patients worldwide have had the Visian ICL™ procedure. The lens has been subjected to numerous scientific studies and continuing refinement over time. In a rigorous US clinical trial, the satisfaction rate among patients was impressive: 99.4% reported satisfaction three years after the procedure. Visian ICL™ is being introduced by STAAR Surgical, Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products. If you are considering vision correction options, you are encouraged to contact Dr. Alan Faulkner at 792-EYES (3937) to discuss the possibilities of Visian ICL™, the new 21st century option for vision correction. Dr. Faulkner is the only certified Visian surgeon performing procedures in Hawaii.